Biodesix, Inc.

NASDAQ:BDSX

1.39 (USD) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018
Revenue 49.08738.21254.50645.55724.55220.432
Cost of Revenue 15.87614.15430.51821.9986.0744.406
Gross Profit 33.21124.05823.98823.55918.47816.026
Gross Profit Ratio 0.6770.630.440.5170.7530.784
Reseach & Development Expenses 9.98813.10212.78910.81810.4688.188
General & Administrative Expenses 000030.63725.899
Selling & Marketing Expenses 061.46250.51734.85730.63725.899
SG&A 64.52161.46250.51734.85730.63725.899
Other Expenses 0.0060.109-0.0090.422-2.379-1.235
Operating Expenses 74.50974.56463.30645.67541.10534.087
Operating Income -41.298-50.506-39.318-22.116-22.627-23.461
Operating Income Ratio -0.841-1.322-0.721-0.485-0.922-1.148
Total Other Income Expenses Net -10.848-14.941-3.841-9.234-8.099-5.213
Income Before Tax -52.146-65.447-43.159-31.35-30.726-26.166
Income Before Tax Ratio -1.062-1.713-0.792-0.688-1.251-1.281
Income Tax Expense 5.33914.9411.3215.1230.6290.211
Net Income -52.146-80.388-44.48-36.473-31.355-26.166
Net Income Ratio -1.062-2.104-0.816-0.801-1.277-1.281
EPS -0.64-1.91-1.63-1.37-1.23-0.99
EPS Diluted -0.64-1.91-1.63-1.37-1.23-0.99
EBITDA -35.791-50.397-39.327-21.676-22.158-17.532
EBITDA Ratio -0.729-1.319-0.722-0.476-0.902-0.858